Clinical Trial

Primary Surgical Prevention of Breast Cancer-related Lymphedema

Study acronym: LYMPHA
Recruiting
View on ClinicalTrials.gov →
Summary
Lymphedema refers to edema caused by insufficient drainage of interstitial fluid through the lymphatic circulation system. It occurs mainly in the upper and lower extremities and causes chronic inflammation, and finally fibrous adipose tissue is replaced. In this study, the'LYMPHA' (Lymphatic microsurgical preventing healing approach) procedure, which connects lymphatic vessels drained from the arm to the side branches of the axillary vein, contributes to the prevention of lymphedema in patients undergoing axillary lymph node dissection for breast cancer. Investigator aim to help patients' quality of life by prospectively analyzing the effects and applying them to clinical practice, reducing the incidence of lymphedema.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2020-12-24.
Status change: Not Yet Recruiting → Recruiting 2023-10-09
Trial Details
NCT Number NCT04687956
Lead Sponsor Gangnam Severance Hospital
Conditions Lymphedema, Mastectomy, Breast Cancer
Enrollment 72 participants
Start Date 2021-02-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-10-11